Moderate riskFDA DrugClass III

Trokendi XR topiramate capsules recalled for failed dissolution

Supernus Pharmaceuticals is recalling one lot of Trokendi XR (topiramate extended-release capsules, 25 mg, 30 count) because it failed dissolution specifications. The FDA has classified the recall as Class III, and no injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. Talk to your pharmacist or prescriber before stopping it.
  2. Check whether your bottle is Lot 2075801 with expiration date 31-Oct-2029 (NDC 17772-101-30).
  3. The notice doesn't say how to get a refund or replacement; contact Supernus Pharmaceuticals or the pharmacy where you bought it.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-101-30.
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
15,853 bottles
Illnesses reported
None reported
Manufactured in
9715 Key West Ave, N/A, Rockville, MD, United States
Classification
Class III
Recall number
D-0758-2026

In the FDA's words

Description
Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-101-30. Failed Dissolution Specifications Lot # 2075801, Exp Date: 31-Oct-2029. Distribution: US Nationwide. Affected quantity: 15,853 bottles
Hazard
Failed Dissolution Specifications

More from Supernus

Related topics

PotencyDrugsSold nationwideMore from FDA Drug